Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Ciwujia Granules for Psycho-Neurological Symptoms in Ovarian Cancer
NCT07050563Not yet recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- Oct 2025
- Primary completion
- Sep 2028
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of eleuthero (2 arms), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Primary endpoint: Psychoneurological Symptom Cluster Score (MDASI-OC) at 12 months. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
eleuthero
Beyond the preview
Go deeper on NCT07050563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07050563.